ESROGLIM M1 Tablets are a combination anti-diabetic medicine containing Metformin Hydrochloride 500 mg (prolonged-release) and Glimepiride 1 mg. This bilayered tablet offers both immediate and sustained action, helping patients with type 2 diabetes mellitus achieve stable blood sugar control throughout the day.
Form: Uncoated bilayered tablets
Composition:
Metformin Hydrochloride IP (Prolonged-release) – 500 mg
Glimepiride IP – 1 mg
Colour: Ponceau 4R
Pack Size: 10 × 15 Tablets
MRP: ₹119/-
Metformin reduces glucose production in the liver and increases insulin sensitivity, while Glimepiride stimulates the pancreas to release insulin. Together, they target both insulin resistance and insufficient insulin production, providing effective glycemic control.
✔ Dual mechanism for better blood sugar regulation
✔ Prolonged-release Metformin ensures all-day glucose stability
✔ Low-dose Glimepiride reduces hypoglycemia risk
✔ Bilayered design combines immediate and sustained effects
✔ Convenient once-daily dosing improves adherence
Ideal for patients requiring moderate control with minimal side effects, ESROGLIM M1 offers a balanced treatment option that is both effective and well-tolerated.
